🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Waldenström's Macroglobulinemia (lymphoplasmacytic lymphoma, WM) remains in...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2006-09
Trial ID
NCT00422656
Treatments Being Tested
This is a 26 week randomized controlled study. The study consists of, in or...
Status
Completed
Location
VA WNY Healthcare System
Start Date
2010-09
Trial ID
NCT01186822
Treatments Being Tested
A phase IV study to characterize safety of Elunate® (Fruquintinib) in Chine...
Status
Completed
Location
Shanghai Dongfang Hospital
Start Date
2019-04-20
Trial ID
NCT04005066
Treatments Being Tested
The purpose of this study is to better define the intensive care unit popul...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02689531
This retrospective cohort study investigates the effects of SGLT2 inhibitor...
Status
Active Not Recruiting
Location
University Medical Centre Ljubljana
Start Date
2019-01-01
Trial ID
NCT07478575
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
This study evaluated the effects of a multidisciplinary biopsychosocial pro...
Status
Completed
Location
University Hospital Osijek
Start Date
2021-11-15
Trial ID
NCT07406711
Treatments Being Tested
Cognitive impairment is a key disabling feature of SZ. The impairment affec...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01879709
Treatments Being Tested